Skip to main content
. 2018 Nov 9;42:e167. doi: 10.26633/RPSP.2018.167

TABLE 1. Population characteristics in a study of the impact of pneumococcal conjugated vaccine (PCV13) introduction to the National Immunization Program in Argentina, among children less than 5 years of age in Concordia, Argentina, by study period.

Variable Pre-introduction of PCV13 (2002 – 2005) Post-introduction of PCV13 (2014 – 2016) P
n % n %
Community acquired pneumonia (CAP) 768 330
Consolidated CAP and pleural effusion (probably) 434 56.5 92 27.9 < 0.0001
Pneumococcal pneumonia (confirmed) 25 3.3 0 0 < 0.0001
Age (months)
0 – 11 288 37.5 136 41.21
12 – 23 199 25.9 91 27.6
24 – 59 281 36.5 103 31.2
Gender
Female 364 47.4 153 46.3
Male 404 52.6 177 53.6
Socioeconomic status
1 2 0.6
2 14 4.2
3 90 27.3
4 203 61.5
5 21 6.3
Nutritional status, eutrophic 619 82.0 281 85.1
Nursery school/pre-kindergarten 51 6.8 39 11.8 0.004
Receiving antibiotics in previous 3 months 191 25.0 46 13.9 0.0001
Hospitalization in previous 3 months 55 16.7
Underlying disease 347 45.5 162 49.1
Outcome
Cured 758 98.9 327 99.1
Derived 3 0.3 2 0.6
Deceased 5 0.6 1 0.3
Health care service
Inpatient 488 63.5 211 63.9
Outpatient 280 36.4 117 35.4
a

Chi-squared test.

Source: Prepared by the authors from the study results.